Insider Trading & Ownership - Moat Ross

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Moat Ross

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-09-01
Exercise
2023-09-06
7:07 pm
N/A
N/A
Kiniksa Pharmaceuticals Ltd.KNSAMoat Ross
CHIEF COMMERCIAL OFFICER
3,471$068,952
(Direct)
View
2023-09-01
Tax Withholding
2023-09-06
7:07 pm
N/A
N/A
Kiniksa Pharmaceuticals Ltd.KNSAMoat Ross
CHIEF COMMERCIAL OFFICER
1,896$17.7668,952
(Direct)
View
2023-09-01
Option Award
2023-09-06
7:07 pm
N/A
N/A
Kiniksa Pharmaceuticals Ltd.KNSAMoat Ross
CHIEF COMMERCIAL OFFICER
45,113$068,952
(Direct)
View
2023-07-15
Option Award
2023-09-06
7:07 pm
N/A
N/A
Kiniksa Pharmaceuticals Ltd.KNSAMoat Ross
CHIEF COMMERCIAL OFFICER
292$12.3568,952
(Direct)
View
2023-04-10
Exercise
2023-04-11
5:06 pm
N/A
N/A
Kiniksa Pharmaceuticals Ltd.KNSAMoat Ross
CHIEF COMMERCIAL OFFICER
2,477$019,984
(Direct)
View
2023-04-10
Tax Withholding
2023-04-11
5:06 pm
N/A
N/A
Kiniksa Pharmaceuticals Ltd.KNSAMoat Ross
CHIEF COMMERCIAL OFFICER
1,353$10.7119,984
(Direct)
View
2023-04-01
Option Award
2023-04-03
4:30 pm
N/A
2033-03-31
Kiniksa Pharmaceuticals Ltd.KNSAMoat Ross
CHIEF COMMERCIAL OFFICER
45,113$045,113
(Direct)
View
2023-03-16
Exercise
2023-03-20
5:19 pm
N/A
N/A
Kiniksa Pharmaceuticals Ltd.KNSAMoat Ross
CHIEF COMMERCIAL OFFICER
3,131$013,417
(Direct)
View
2023-03-16
Tax Withholding
2023-03-20
5:19 pm
N/A
N/A
Kiniksa Pharmaceuticals Ltd.KNSAMoat Ross
CHIEF COMMERCIAL OFFICER
543$11.4613,417
(Direct)
View
2023-01-15
Option Award
2023-03-20
5:19 pm
N/A
N/A
Kiniksa Pharmaceuticals Ltd.KNSAMoat Ross
CHIEF COMMERCIAL OFFICER
1,844$9.5613,417
(Direct)
View
2023-03-20
Tax Withholding
2023-03-20
5:19 pm
N/A
N/A
Kiniksa Pharmaceuticals Ltd.KNSAMoat Ross
CHIEF COMMERCIAL OFFICER
1,167$11.1213,417
(Direct)
View
2022-09-02
Exercise
2022-09-06
4:12 pm
N/A
N/A
Kiniksa Pharmaceuticals Ltd.KNSAMoat Ross
CHIEF COMMERCIAL OFFICER
995$080,514
(Direct)
View
2022-09-01
Option Award
2022-09-06
4:12 pm
N/A
2032-08-31
Kiniksa Pharmaceuticals Ltd.KNSAMoat Ross
CHIEF COMMERCIAL OFFICER
69,368$080,514
(Direct)
View
2022-07-15
Option Award
2022-09-06
4:12 pm
N/A
N/A
Kiniksa Pharmaceuticals Ltd.KNSAMoat Ross
CHIEF COMMERCIAL OFFICER
360$9.5680,514
(Direct)
View
2022-09-02
Tax Withholding
2022-09-06
4:12 pm
N/A
N/A
Kiniksa Pharmaceuticals Ltd.KNSAMoat Ross
CHIEF COMMERCIAL OFFICER
563$11.4480,514
(Direct)
View
2022-04-07
Option Award
2022-04-11
4:30 pm
N/A
2032-04-06
Kiniksa Pharmaceuticals Ltd.KNSAMoat Ross
CHIEF COMMERCIAL OFFICER
69,368$069,368
(Direct)
View
2022-03-21
Exercise
2022-03-23
4:30 pm
N/A
N/A
Kiniksa Pharmaceuticals Ltd.KNSAMoat Ross
CHIEF COMMERCIAL OFFICER
2,270$07,372
(Direct)
View
2022-03-21
Tax Withholding
2022-03-23
4:30 pm
N/A
N/A
Kiniksa Pharmaceuticals Ltd.KNSAMoat Ross
CHIEF COMMERCIAL OFFICER
1,240$10.987,372
(Direct)
View
2022-03-16
Exercise
2022-03-18
4:39 pm
N/A
N/A
Kiniksa Pharmaceuticals Ltd.KNSAMoat Ross
Chief Commercial Officer
995$09,324
(Direct)
View
2021-07-15
Option Award
2022-03-18
4:39 pm
N/A
N/A
Kiniksa Pharmaceuticals Ltd.KNSAMoat Ross
Chief Commercial Officer
963$11.499,324
(Direct)
View
2022-01-15
Option Award
2022-03-18
4:39 pm
N/A
N/A
Kiniksa Pharmaceuticals Ltd.KNSAMoat Ross
Chief Commercial Officer
1,546$9.639,324
(Direct)
View
2022-03-16
Tax Withholding
2022-03-18
4:39 pm
N/A
N/A
Kiniksa Pharmaceuticals Ltd.KNSAMoat Ross
Chief Commercial Officer
544$10.139,324
(Direct)
View
2021-09-02
Option Award
2021-09-07
5:16 pm
N/A
2031-09-01
Kiniksa Pharmaceuticals Ltd.KNSAMoat Ross
ARCALYST General Manager
11,931$011,931
(Direct)
View

Ownership
2021-04-15
5:32 pm
N/A
N/A
Kiniksa Pharmaceuticals Ltd.KNSAMoat Ross
Group VP & Rilonacept GM
0$0109,720
(Direct)
View